Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial
Hatem Soliman, Deanna Hogue, Hyo S. Han, Blaise Mooney, Ricardo Costa, Marie Catherine Lee, Bethany L. Niell, Angela Williams, Alec Chau, Shannon Falcon, Aixa Soyano, Avan Armaghani, Nazanin Khakpour, R. Jared Weinfurtner, Susan Hoover, John V. Kiluk, Christine Laronga, Marilin Rosa, Hung T. Khong, Brian J. Czerniecki
Topics & Concepts
MedicineOncolytic virusTriple-negative breast cancerBreast cancerCyclophosphamideInternal medicineOncologyClinical endpointChemotherapyDoxorubicinPhases of clinical researchPaclitaxelCancerSurgeryClinical trialVirus-based gene therapy researchCAR-T cell therapy researchRNA Interference and Gene Delivery